결과 페이지 2 - 부문: 보건의료 업종: 의약품 제조업체 - 일반 주식 시장 - 시세 및 가격
가격, 시가 총액, PE 및 EPS가 포함된 모든 주식 목록
모든 나라들
모든 거래소
- {{item.name}}
- 모든 거래소
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (12)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (44)
- Helsinki (2)
- HKSE (1)
- IOB (16)
- Istanbul (1)
- KSE (3)
- Mexico (14)
- Milan (5)
- Munich (1)
- NSE (8)
- NYSE (6)
- OTC Markets OTCPK (28)
- OTC Markets OTCQX (4)
- Paris (2)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (4)
- Shenzhen (4)
- Stockholm (3)
- Swiss (5)
- Taipei Exchange (1)
- Tech Market Large (4)
- Tech Market Middle (1)
- Tech Market Small (1)
- Tokyo (7)
- Vienna (13)
- XETRA (12)
보건의료 (243)
- {{item.name}}
- 모든 업종
- 보건의료 (243)
의약품 제조업체 - 일반 (243)
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | 예측 |
|---|
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | 예측 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
| Roche Holding AG RHO6.F | €38.88 42.5 USD |
+0.47
|
€251.02B 274.4B USD | €6.00 6.56 USD | €38.81 42.42 USD | €38.88 42.5 USD | €251.02B 274.4B USD | 24.44 | €1.59 1.74 USD | ||
| Novartis AG N1VS34.SA | R$68.53 13.89 USD |
0
|
R$1.32T 268.27B USD | R$0.00 0 USD | R$68.53 13.89 USD | R$68.53 13.89 USD | R$1.32T 268.27B USD | 17.70 | R$3.87 0.78 USD | ||
| AstraZeneca PLC ZEG.F | €152.65 166.87 USD |
+0.1
|
€236.92B 258.98B USD | €335.00 366.2 USD | €150.90 164.95 USD | €152.80 167.03 USD | €236.92B 258.98B USD | 29.52 | €5.17 5.65 USD | ||
| AstraZeneca PLC ZEGA.F | €75.00 81.99 USD |
-2.6
|
€236.92B 258.98B USD | €190.00 207.7 USD | €75.00 81.99 USD | €75.00 81.99 USD | €236.92B 258.98B USD | 28.95 | €2.59 2.83 USD | ||
| Gilead Sciences, Inc. GILD.BA | ARS 46,420.00 54.87 USD |
-0.09
|
ARS 218.79T 258.62B USD | ARS 201.00 0.24 USD | ARS 45,540.00 53.83 USD | ARS 46,720.00 55.22 USD | ARS 218.79T 258.62B USD | 5.10 | ARS 9.09K 10.75 USD | ||
| Merck & Co., Inc. MRK.SN | $89.12 — |
+12.61
|
$255.60B — | $0.00 — | $89.12 — | $89.12 — | $255.60B — | 11.78 | $7.56 — | ||
| Merck & Co., Inc. MRCK34.SA | R$62.22 12.61 USD |
+1.67
|
R$1.24T 250.41B USD | R$9.96K 2.02K USD | R$60.54 12.27 USD | R$62.60 12.69 USD | R$1.24T 250.41B USD | 12.41 | R$5.01 1.02 USD | ||
| Merck & Co., Inc. MRK.MX | MX$1,698.09 100.55 USD |
+0.18
|
MX$4.21T 249.56B USD | MX$6.33K 375.05 USD | MX$1,695.00 100.36 USD | MX$1,740.00 103.03 USD | MX$4.21T 249.56B USD | 12.25 | MX$138.56 8.2 USD | ||
| Pfizer Inc. PFE.BA | ARS 9,370.00 11.08 USD |
-1.83
|
ARS 206.54T 244.13B USD | ARS 21.88K 25.86 USD | ARS 9,260.00 10.95 USD | ARS 9,735.00 11.51 USD | ARS 206.54T 244.13B USD | 1.93 | ARS 4.84K 5.73 USD | ||
| Novartis AG NOTA.F | €111.00 121.34 USD |
-0.89
|
€219.37B 239.8B USD | €1.00 1.09 USD | €111.00 121.34 USD | €111.00 121.34 USD | €219.37B 239.8B USD | 17.67 | €6.28 6.86 USD | ||
| Merck & Co., Inc. 6MK.DE | €81.20 88.76 USD |
+0.87
|
€201.54B 220.31B USD | €4.75K 5.19K USD | €78.60 85.92 USD | €81.20 88.76 USD | €201.54B 220.31B USD | 12.49 | €6.50 7.11 USD | ||
| Merck & Co., Inc. MRK.VI | €81.10 88.65 USD |
+0.5
|
€201.29B 220.04B USD | €400.00 437.25 USD | €79.40 86.79 USD | €81.10 88.65 USD | €201.29B 220.04B USD | 12.43 | €6.52 7.13 USD | ||
| Merck & Co., Inc. 6MK.F | €80.30 87.78 USD |
0
|
€199.31B 217.87B USD | €2.17K 2.37K USD | €78.40 85.7 USD | €81.70 89.31 USD | €199.31B 217.87B USD | 12.35 | €6.50 7.11 USD | ||
| Amgen Inc. AMGN.MX | MX$6,280.00 371.85 USD |
0
|
MX$3.38T 200.24B USD | MX$233.00 13.8 USD | MX$6,280.00 371.85 USD | MX$6,280.00 371.85 USD | MX$3.38T 200.24B USD | 26.52 | MX$236.76 14.02 USD | ||
| Amgen Inc. AMGN34.SA | R$63.84 12.94 USD |
+0.3
|
R$962.54B 195.09B USD | R$37.00 7.5 USD | R$63.84 12.94 USD | R$64.00 12.97 USD | R$962.54B 195.09B USD | 26.05 | R$2.45 0.5 USD | ||
| Amgen Inc. AMGN.VI | €290.15 317.17 USD |
-1.49
|
€156.24B 170.79B USD | €154.00 168.34 USD | €288.75 315.64 USD | €291.80 318.98 USD | €156.24B 170.79B USD | 26.04 | €11.14 12.18 USD | ||
| Amgen Inc. AMG.DE | €290.10 317.12 USD |
-1.28
|
€156.21B 170.76B USD | €963.00 1.05K USD | €286.10 312.75 USD | €292.00 319.2 USD | €156.21B 170.76B USD | 26.11 | €11.11 12.14 USD | ||
| Amgen Inc. AMG.F | €287.20 313.95 USD |
-1.93
|
€156.10B 170.64B USD | €193.00 210.98 USD | €287.20 313.95 USD | €287.20 313.95 USD | €156.10B 170.64B USD | 25.85 | €11.11 12.14 USD | ||
| GSK plc GSK.BA | ARS 17,650.00 20.86 USD |
-0.26
|
ARS 141.83T 167.65B USD | ARS 289.00 0.34 USD | ARS 17,460.00 20.64 USD | ARS 17,670.00 20.89 USD | ARS 141.83T 167.65B USD | 14.32 | ARS 1.23K 1.46 USD | ||
| Gilead Sciences, Inc. GILD.MX | MX$2,264.00 134.06 USD |
-2.08
|
MX$2.81T 166.32B USD | MX$38.00 2.25 USD | MX$2,264.00 134.06 USD | MX$2,264.00 134.06 USD | MX$2.81T 166.32B USD | 19.12 | MX$118.41 7.01 USD | ||
| Gilead Sciences, Inc. GILD34.SA | R$329.60 66.8 USD |
-0.83
|
R$817.86B 165.77B USD | R$5.00 1.01 USD | R$329.60 66.8 USD | R$329.60 66.8 USD | R$817.86B 165.77B USD | 19.26 | R$17.11 3.47 USD | ||
| Bristol-Myers Squibb Company BMY.BA | ARS 23,290.00 27.53 USD |
-3.92
|
ARS 139.44T 164.82B USD | ARS 2.75K 3.26 USD | ARS 22,320.00 26.38 USD | ARS 23,800.00 28.13 USD | ARS 139.44T 164.82B USD | 5.56 | ARS 4.18K 4.94 USD | ||
| Pfizer Inc. PFE.MX | MX$460.99 27.3 USD |
-2.16
|
MX$2.69T 159.05B USD | MX$955.00 56.55 USD | MX$459.01 27.18 USD | MX$466.00 27.59 USD | MX$2.69T 159.05B USD | 14.62 | MX$31.53 1.87 USD | ||
| Pfizer Inc. PFE.SN | $27.75 — |
+6.49
|
$157.78B — | $0.00 — | $27.75 — | $27.75 — | $157.78B — | 16.13 | $1.72 — | ||
| Amgen Inc. 0R0T.IL | $287.63 — |
+0.57
|
$157.63B — | $1.00 — | $0.00 — | $0.00 — | $157.63B — | 19.38 | $14.84 — | ||
| Pfizer Inc. PFIZ34.SA | R$33.20 6.73 USD |
-2.38
|
R$775.70B 157.22B USD | R$53.37K 10.82K USD | R$33.08 6.7 USD | R$34.36 6.96 USD | R$775.70B 157.22B USD | 14.56 | R$2.28 0.46 USD | ||
| Gilead Sciences, Inc. GILD.SN | $110.29 — |
-0.13
|
$152.91B — | $0.00 — | $110.29 — | $110.29 — | $152.91B — | 17.07 | $6.46 — | ||
| Gilead Sciences, Inc. GIS.F | €108.66 118.78 USD |
+2.16
|
€134.81B 147.37B USD | €146.00 159.6 USD | €107.94 117.99 USD | €109.28 119.46 USD | €134.81B 147.37B USD | 19.57 | €5.55 6.07 USD | ||
| Gilead Sciences, Inc. GIS.DE | €107.00 116.97 USD |
-1.71
|
€134.01B 146.49B USD | €4.00K 4.37K USD | €105.42 115.24 USD | €109.64 119.85 USD | €134.01B 146.49B USD | 19.27 | €5.55 6.07 USD | ||
| Gilead Sciences, Inc. GILD.VI | €106.90 116.86 USD |
-2.03
|
€134.01B 146.49B USD | €420.00 459.12 USD | €106.90 116.86 USD | €109.60 119.81 USD | €134.01B 146.49B USD | 19.19 | €5.57 6.09 USD | ||
| Pfizer Inc. PFE.VI | €21.72 23.74 USD |
-3.36
|
€126.51B 138.29B USD | €1.54K 1.69K USD | €21.72 23.74 USD | €22.14 24.2 USD | €126.51B 138.29B USD | 14.67 | €1.48 1.62 USD | ||
| Pfizer Inc. PFEB.F | €6.90 7.54 USD |
-0.72
|
€126.51B 138.29B USD | €50.00 54.66 USD | €6.90 7.54 USD | €6.90 7.54 USD | €126.51B 138.29B USD | 13.80 | €0.50 0.55 USD | ||
| Sanofi SNW2.F | €44.40 48.54 USD |
-0.89
|
€109.84B 120.07B USD | €20.00 21.86 USD | €44.40 48.54 USD | €44.60 48.75 USD | €109.84B 120.07B USD | 16.94 | €2.62 2.86 USD | ||
| Sanofi SANO.VI | €89.83 98.2 USD |
+0.2
|
€109.84B 120.07B USD | €253.00 276.56 USD | €89.42 97.75 USD | €90.02 98.4 USD | €109.84B 120.07B USD | 17.14 | €5.24 5.73 USD | ||
| Sanofi SNW.F | €89.83 98.2 USD |
-0.49
|
€109.84B 120.07B USD | €1.28K 1.4K USD | €89.41 97.74 USD | €89.83 98.2 USD | €109.84B 120.07B USD | 17.14 | €5.24 5.73 USD | ||
| Bristol-Myers Squibb Company BMY.MX | MX$899.00 53.23 USD |
0
|
MX$1.83T 108.41B USD | MX$4.00 0.24 USD | MX$899.00 53.23 USD | MX$899.00 53.23 USD | MX$1.83T 108.41B USD | 16.52 | MX$54.39 3.22 USD | ||
| Bristol-Myers Squibb Company BMYB34.SA | R$247.00 50.06 USD |
-5.04
|
R$526.92B 106.8B USD | R$210.00 42.56 USD | R$247.00 50.06 USD | R$248.06 50.28 USD | R$526.92B 106.8B USD | 15.70 | R$15.73 3.19 USD | ||
| GSK plc GSKN.MX | MX$864.00 51.16 USD |
-0.2
|
MX$1.77T 104.55B USD | MX$73.00 4.32 USD | MX$864.00 51.16 USD | MX$864.00 51.16 USD | MX$1.77T 104.55B USD | 13.47 | MX$64.11 3.8 USD | ||
| GSK plc G1SK34.SA | R$50.69 10.27 USD |
+0.84
|
R$509.16B 103.2B USD | R$0.00 0 USD | R$50.69 10.27 USD | R$50.69 10.27 USD | R$509.16B 103.2B USD | 13.66 | R$3.71 0.75 USD | ||
| GSK GLAXF | $22.95 — |
+0.88
|
$95.50B — | $1.13K — | $23.25 — | $23.50 — | $95.50B — | 13.11 | $1.75 — | ||
| Bristol-Myers Squibb Company BRM.F | €39.77 43.47 USD |
-7.24
|
€85.41B 93.37B USD | €709.00 775.03 USD | €39.35 43.01 USD | €41.39 45.24 USD | €85.41B 93.37B USD | 15.59 | €2.55 2.79 USD | ||
| Bristol-Myers Squibb Company BMYS.VI | €40.35 44.11 USD |
-5.48
|
€85.41B 93.37B USD | €448.00 489.72 USD | €39.81 43.52 USD | €41.71 45.59 USD | €85.41B 93.37B USD | 15.76 | €2.56 2.8 USD | ||
| Bristol-Myers Squibb Company BRM.DE | €40.41 44.17 USD |
-5.43
|
€85.41B 93.37B USD | €14.82K 16.19K USD | €39.22 42.87 USD | €42.03 45.94 USD | €85.41B 93.37B USD | 15.84 | €2.55 2.79 USD | ||
| Chugai Pharmaceutical CHGCF | $52.48 — |
-1.83
|
$86.37B — | $500.00 — | $52.05 — | $52.18 — | $86.37B — | 33.85 | $1.55 — | ||
| Chugai Pharmaceutical Co., Ltd. CUP.F | €44.61 48.76 USD |
-0.18
|
€74.26B 81.18B USD | €50.00 54.66 USD | €44.54 48.69 USD | €45.10 49.3 USD | €74.26B 81.18B USD | 33.29 | €1.34 1.46 USD | ||
| Biogen Inc. BIIB.BA | ARS 19,160.00 22.65 USD |
+1.48
|
ARS 34.04T 40.23B USD | ARS 1.78K 2.11 USD | ARS 18,690.00 22.09 USD | ARS 19,310.00 22.83 USD | ARS 34.04T 40.23B USD | 1.24 | ARS 15.44K 18.26 USD | ||
| Daiichi Sankyo Company, Limited D4S.F | €19.79 21.63 USD |
+3.61
|
€36.63B 40.04B USD | €50.00 54.66 USD | €19.20 20.98 USD | €19.79 21.63 USD | €36.63B 40.04B USD | 23.84 | €0.83 0.91 USD | ||
| Bayer Aktiengesellschaft BAYZF | $32.87 — |
-4.81
|
$33.09B — | $380.00 — | $34.27 — | $34.50 — | $33.09B — | 0 | -$0.23 — | ||
| Bayer Aktiengesellschaft BAYA.F | €7.10 7.76 USD |
-1.39
|
€28.55B 31.21B USD | €75.00 81.99 USD | €7.10 7.76 USD | €7.10 7.76 USD | €28.55B 31.21B USD | 0 | -€0.05 -0.05 USD | ||
| Bayer Aktiengesellschaft BAYN.VI | €28.40 31.05 USD |
-4.98
|
€28.55B 31.21B USD | €2.77K 3.02K USD | €28.12 30.73 USD | €29.74 32.5 USD | €28.55B 31.21B USD | 0 | -€0.20 -0.2 USD | ||
| Bayer Aktiengesellschaft BAYER.BD | HUF 10,954.00 30.3 USD |
-2.54
|
HUF 10.99T 30.39B USD | HUF 200.00 0.55 USD | HUF 10,954.00 30.3 USD | HUF 10,954.00 30.3 USD | HUF 10.99T 30.39B USD | 0 | -HUF 76.68 -0.2 USD | ||
| Biogen Inc. BIIB.MX | MX$3,060.00 181.19 USD |
+9.68
|
MX$448.91B 26.58B USD | MX$200.00 11.84 USD | MX$3,060.00 181.19 USD | MX$3,080.00 182.37 USD | MX$448.91B 26.58B USD | 15.22 | MX$201.04 11.9 USD | ||
| Otsuka Holdings Co., Ltd. OS1.F | €46.00 50.28 USD |
+2.22
|
€24.29B 26.56B USD | €26.00 28.42 USD | €46.00 50.28 USD | €46.00 50.28 USD | €24.29B 26.56B USD | 10.87 | €4.23 4.62 USD | ||
| Biogen Inc. BIIB34.SA | R$145.65 29.52 USD |
-1.01
|
R$128.72B 26.09B USD | R$50.00 10.13 USD | R$145.65 29.52 USD | R$145.65 29.52 USD | R$128.72B 26.09B USD | 15.07 | R$9.66 1.96 USD | ||
| Biogen Inc. IDP.F | €145.70 159.27 USD |
+1.89
|
€21.37B 23.37B USD | €100.00 109.31 USD | €140.45 153.53 USD | €145.70 159.27 USD | €21.37B 23.37B USD | 15.45 | €9.43 10.31 USD | ||
| Biogen Inc. BIIB.VI | €144.85 158.34 USD |
+1.61
|
€21.25B 23.23B USD | €0.00 0 USD | €141.40 154.57 USD | €144.85 158.34 USD | €21.25B 23.23B USD | 15.31 | €9.46 10.34 USD | ||
| Biogen Inc. IDP.DE | €144.65 158.12 USD |
+1.19
|
€21.22B 23.2B USD | €210.00 229.56 USD | €141.20 154.35 USD | €144.75 158.23 USD | €21.22B 23.2B USD | 15.33 | €9.43 10.31 USD | ||
| Astellas Pharma ALPMF | $12.20 — |
+2.26
|
$21.85B — | $700.00 — | $11.92 — | $12.20 — | $21.85B — | 27.11 | $0.45 — | ||
| Astellas Pharma Inc. YPH.F | €10.24 11.19 USD |
+1.34
|
€18.72B 20.47B USD | €50.00 54.66 USD | €10.24 11.19 USD | €10.30 11.25 USD | €18.72B 20.47B USD | 26.25 | €0.39 0.43 USD | ||
| Astellas Pharma Inc. YPHA.F | €10.20 11.15 USD |
+0.99
|
€18.72B 20.47B USD | €379.00 414.3 USD | €10.20 11.15 USD | €10.20 11.15 USD | €18.72B 20.47B USD | 26.15 | €0.39 0.43 USD | ||
| Cipla Limited CIPLA.BO | ₹1,531.65 18.53 USD |
+0.38
|
₹1.24T 14.97B USD | ₹30.58K 369.98 USD | ₹1,523.00 18.43 USD | ₹1,534.60 18.57 USD | ₹1.24T 14.97B USD | 22.72 | ₹67.39 0.82 USD | ||
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | €52.20 57.06 USD |
-0.1
|
€10.67B 11.66B USD | €0.00 0 USD | €52.20 57.06 USD | €52.45 57.33 USD | €10.67B 11.66B USD | 27.04 | €1.93 2.11 USD | ||
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | €52.00 56.84 USD |
-0.38
|
€10.65B 11.64B USD | €55.00 60.12 USD | €51.45 56.24 USD | €52.30 57.17 USD | €10.65B 11.64B USD | 26.94 | €1.93 2.11 USD | ||
| Orion Oyj ORINF | $81.30 — |
0
|
$11.16B — | $100.00 — | $81.30 — | $81.30 — | $11.16B — | 26.05 | $3.12 — | ||
| CSPC Pharmaceutical Group Limited CVG.F | €0.86 0.94 USD |
-1.17
|
€10.08B 11.02B USD | €2.00K 2.19K USD | €0.86 0.94 USD | €0.86 0.94 USD | €10.08B 11.02B USD | 21.47 | €0.04 0.04 USD | ||
| Orion Oyj ORINY | $34.73 — |
+1.85
|
$9.75B — | $2.00 — | $34.18 — | $34.18 — | $9.75B — | 26.71 | $1.30 — | ||
| Orion Oyj OFK0.F | €29.60 32.36 USD |
-0.67
|
€8.41B 9.19B USD | €500.00 546.57 USD | €29.60 32.36 USD | €29.60 32.36 USD | €8.41B 9.19B USD | 26.42 | €1.12 1.22 USD | ||
| Orion Oyj OFK.F | €59.75 65.31 USD |
+0.42
|
€8.41B 9.19B USD | €24.00 26.24 USD | €59.55 65.1 USD | €59.75 65.31 USD | €8.41B 9.19B USD | 26.79 | €2.23 2.44 USD | ||
| Grifols, S.A. GIFOF | $8.81 — |
0
|
$8.60B — | $4.41K — | $8.18 — | $8.25 — | $8.60B — | 16.95 | $0.52 — | ||
| Kyowa Kirin KYKOF | $16.09 — |
+18.48
|
$8.42B — | $100.00 — | $13.58 — | $13.58 — | $8.42B — | 34.23 | $0.47 — | ||
| Grifols GIFLF | $13.90 — |
0
|
$8.25B — | $500.00 — | $14.00 — | $14.00 — | $8.25B — | 27.25 | $0.51 — | ||
| Kyowa Kirin Co., Ltd. KY4.F | €13.70 14.98 USD |
0
|
€7.29B 7.97B USD | €15.00 16.4 USD | €13.70 14.98 USD | €13.70 14.98 USD | €7.29B 7.97B USD | 33.41 | €0.41 0.45 USD | ||
| Grifols, S.A. GIKLY | $6.16 — |
0
|
$7.64B — | $50.00 — | $6.70 — | $6.70 — | $7.64B — | 19.25 | $0.32 — | ||
| Abbott India Limited ABBOTINDIA.BO | ₹29,223.10 353.55 USD |
-1.12
|
₹628.02B 7.6B USD | ₹259.00 3.13 USD | ₹28,720.00 347.46 USD | ₹30,049.05 363.54 USD | ₹628.02B 7.6B USD | 41.15 | ₹710.12 8.59 USD | ||
| Grifols, S.A. G0F.F | €5.15 5.63 USD |
0
|
€6.59B 7.2B USD | €68.00 74.33 USD | €5.15 5.63 USD | €5.15 5.63 USD | €6.59B 7.2B USD | 19.07 | €0.27 0.3 USD | ||
| Grifols, S.A. G0FB.F | €7.30 7.98 USD |
-0.68
|
€6.59B 7.2B USD | €850.00 929.16 USD | €7.30 7.98 USD | €7.30 7.98 USD | €6.59B 7.2B USD | 13.27 | €0.55 0.6 USD | ||
| Grifols, S.A. GRF.VI | €10.60 11.58 USD |
-2.62
|
€6.59B 7.2B USD | €0.00 0 USD | €10.60 11.58 USD | €10.83 11.84 USD | €6.59B 7.2B USD | 19.26 | €0.55 0.6 USD | ||
| Grifols, S.A. OZTA.F | €10.85 11.86 USD |
+0.88
|
€6.59B 7.2B USD | €175.00 191.3 USD | €10.85 11.86 USD | €10.85 11.86 USD | €6.59B 7.2B USD | 19.72 | €0.55 0.6 USD | ||
| Ono Pharmaceutical OPHLF | $11.08 — |
0
|
$6.09B — | $104.00 — | $12.22 — | $12.22 — | $6.09B — | 15.38 | $0.72 — | ||
| Ono Pharmaceutical Co., Ltd. ON4.F | €11.10 12.13 USD |
+1.83
|
€5.25B 5.74B USD | €300.00 327.94 USD | €10.90 11.92 USD | €11.10 12.13 USD | €5.25B 5.74B USD | 17.90 | €0.62 0.68 USD | ||
| Ono Pharmaceutical Co., Ltd. ON4.MU | €11.10 12.13 USD |
+0.91
|
€5.25B 5.74B USD | €0.00 0 USD | €11.00 12.02 USD | €11.10 12.13 USD | €5.25B 5.74B USD | 17.90 | €0.62 0.68 USD | ||
| GlaxoSmithKline Pharmaceuticals Limited GLAXO.BO | ₹2,477.90 29.98 USD |
-0.63
|
₹422.42B 5.11B USD | ₹1.79K 21.67 USD | ₹2,471.00 29.89 USD | ₹2,514.50 30.42 USD | ₹422.42B 5.11B USD | 43.85 | ₹56.50 0.68 USD | ||
| GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS | ₹2,479.40 30 USD |
-0.61
|
₹422.42B 5.11B USD | ₹51.37K 621.52 USD | ₹2,470.90 29.89 USD | ₹2,515.20 30.43 USD | ₹422.42B 5.11B USD | 44.05 | ₹56.28 0.68 USD | ||
| Gland Pharma Limited GLAND.BO | ₹1,830.90 22.15 USD |
+0.21
|
₹301.65B 3.65B USD | ₹2.19K 26.53 USD | ₹1,814.40 21.95 USD | ₹1,859.55 22.5 USD | ₹301.65B 3.65B USD | 38.16 | ₹47.97 0.58 USD | ||
| Gland Pharma Limited GLAND.NS | ₹1,830.00 22.14 USD |
+0.04
|
₹301.50B 3.65B USD | ₹67.38K 815.17 USD | ₹1,812.20 21.92 USD | ₹1,862.50 22.53 USD | ₹301.50B 3.65B USD | 38.16 | ₹47.95 0.58 USD | ||
| PT Kalbe Farma Tbk PTKFF | $0.08 — |
0
|
$3.63B — | $4.00K — | $0.06 — | $0.06 — | $3.63B — | 0 | $0.00 — | ||
| Santen Pharmaceutical SNPHF | $10.11 — |
0
|
$3.28B — | $200.00 — | $12.46 — | $12.64 — | $3.28B — | 16.84 | $0.60 — | ||
| Virbac SA 0NM7.IL | €351.50 384.24 USD |
-1.95
|
€3.00B 3.27B USD | €40.00 43.73 USD | €350.00 382.6 USD | €357.00 390.25 USD | €3.00B 3.27B USD | 25.12 | €13.99 15.29 USD | ||
| Virbac SA V16.F | €347.00 379.32 USD |
-2.12
|
€2.99B 3.27B USD | €2.00 2.19 USD | €347.00 379.32 USD | €353.00 385.88 USD | €2.99B 3.27B USD | 21.83 | €15.89 17.37 USD | ||
| Virbac SA VIRP.PA | €352.50 385.33 USD |
-1.26
|
€2.99B 3.27B USD | €2.50K 2.74K USD | €350.00 382.6 USD | €359.00 392.44 USD | €2.99B 3.27B USD | 22.22 | €15.86 17.34 USD | ||
| Santen Pharmaceutical Co., Ltd. SZD.F | €8.70 9.51 USD |
+3.57
|
€2.83B 3.09B USD | €23.00 25.14 USD | €8.70 9.51 USD | €8.70 9.51 USD | €2.83B 3.09B USD | 16.73 | €0.52 0.57 USD | ||
| Haw Par Corporation Limited HAWPY | $50.80 — |
0
|
$2.81B — | $10.00 — | $46.98 — | $46.98 — | $2.81B — | 14.63 | $3.47 — | ||
| Pfizer Limited PFIZER.NS | ₹5,074.00 61.39 USD |
+0.6
|
₹232.12B 2.81B USD | ₹10.07K 121.85 USD | ₹5,028.00 60.83 USD | ₹5,084.00 61.51 USD | ₹232.12B 2.81B USD | 27.62 | ₹183.68 2.22 USD | ||
| Pfizer Limited PFIZER.BO | ₹5,072.00 61.36 USD |
+0.49
|
₹232.03B 2.81B USD | ₹1.84K 22.26 USD | ₹4,980.15 60.25 USD | ₹5,081.40 61.48 USD | ₹232.03B 2.81B USD | 27.62 | ₹183.61 2.22 USD | ||
| Haw Par HAWPF | $10.66 — |
0
|
$2.58B — | $100.00 — | $10.62 — | $10.62 — | $2.58B — | 12.25 | $0.87 — | ||
| Organon & Co. OGN.MX | MX$138.40 8.19 USD |
+0.29
|
MX$36.73B 2.17B USD | MX$10.00 0.59 USD | MX$138.40 8.19 USD | MX$138.40 8.19 USD | MX$36.73B 2.17B USD | 3.95 | MX$34.99 2.07 USD | ||
| Organon & Co. 7XP.F | €6.48 7.08 USD |
-0.43
|
€1.71B 1.87B USD | €2.01K 2.19K USD | €6.44 7.04 USD | €6.63 7.25 USD | €1.71B 1.87B USD | 3.95 | €1.64 1.79 USD | ||
| Luye Pharma Group Ltd. LUP.F | €0.35 0.38 USD |
-1.69
|
€1.44B 1.57B USD | €20.00 21.86 USD | €0.35 0.38 USD | €0.35 0.38 USD | €1.44B 1.57B USD | 34.79 | €0.01 0.01 USD | ||
| Cosmo Pharmaceuticals CMOPF | $81.79 — |
0
|
$1.30B — | $200.00 — | $55.00 — | $55.00 — | $1.30B — | 19.70 | $4.15 — | ||
| Sanofi India Limited SANOFI.NS | ₹4,581.10 55.42 USD |
-0.1
|
₹105.87B 1.28B USD | ₹10.30K 124.66 USD | ₹4,560.00 55.17 USD | ₹4,611.00 55.79 USD | ₹105.87B 1.28B USD | 29.58 | ₹154.84 1.87 USD | ||
|
좋아하는 주식 없음
아직 즐겨찾는 주식이 없습니다. 여기에서 보려면 즐겨찾기에 추가하세요. |
|||||||||||
- {{ link.label }} {{link}}